Department of Laboratory Medicine, Althaia Xarxa Assistencial Universitària de Manresa, Manresa, Spain
Facultat de Medicina, Universitat de Vic, Universitat Central de Catalunya, Vic, Spain.
In Vivo. 2020 Mar-Apr;34(2):715-722. doi: 10.21873/invivo.11829.
BACKGROUND/AIM: There are two strategies for the interpretation of tumor markers (TM) in fluid effusions: i) high cut-off and ii) fluid/serum ratio (F/S) and low cut-off. The objective of this study is to compare these two strategies and to determine whether diagnostic accuracy improves by the identification of possible false positives using Adenosine deaminase (ADA), C reactive protein (CRP) and % of polymorphonuclear cells (%PN).
We studied 157 ascitic fluids, 74 of which were malignant. ADA, CRP and %PN were determined in ascitic fluid, and Carcinoembryonic antigen (CEA), Cancer antigen 72-4 (CA72-4), Cancer antigen CA19-9 and Cancer antigen 15-3 (CA15-3) in both fluid and serum.
The strategy of high cut-off showed 59.5% sensitivity at 100% specificity. The F/S strategy showed 75.7% sensitivity at 95.2% specificity. Subclassifying cases with ADA, CRP and %PN negative showed 67.5% sensitivity at 100% specificity for high cut-off and for the F/S strategy was 81.7% sensitivity at 98.7% specificity.
The strategy of F/S with negative ADA, CRP and %PN allow the best interpretation for TM in the ascitic fluid.
背景/目的:在体液中肿瘤标志物(TM)的解释有两种策略:i)高截断值和 ii)液体/血清比值(F/S)和低截断值。本研究的目的是比较这两种策略,并通过鉴定可能的假阳性(使用腺苷脱氨酶(ADA)、C 反应蛋白(CRP)和中性粒细胞百分比(%PN))来确定诊断准确性是否提高。
我们研究了 157 份腹水,其中 74 份为恶性。在腹水和血清中测定 ADA、CRP 和 %PN,在液体和血清中测定癌胚抗原(CEA)、癌症抗原 72-4(CA72-4)、癌症抗原 CA19-9 和癌症抗原 15-3(CA15-3)。
高截断值策略的敏感性为 59.5%,特异性为 100%。F/S 策略的敏感性为 75.7%,特异性为 95.2%。将 ADA、CRP 和 %PN 阴性的病例进行亚分类,高截断值策略的敏感性为 67.5%,特异性为 100%,F/S 策略的敏感性为 81.7%,特异性为 98.7%。
ADA、CRP 和 %PN 阴性的 F/S 策略最适合解释腹水的 TM。